Are Treatments for Common Mental Disorders Also Effective for Functional Symptoms and Disorder?

Mayou, Richard

doi:10.1097/psy.0b013e31815b00a6

Cited by 25 publications

(16 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Circumstantially at least, known vulnerability factors such as female gender, increased symptomatic risk with increasing age into adolescence, history of exposure to life adversity, family history, and anxious or inhibited temperament are shared by individuals suffering from FSS, anxiety, and/or depression. There is also evidence that anxiety, depressive, and somatoform disorders/functional somatic syndromes respond to similar treatments, particularly to cognitive‐behavioral psychotherapies and antidepressant medications, and that effective treatment of any one disorder appears to improve overall functional status and the symptoms of the comorbid disorders (Kroenke, 2007; Mayou, 2007). As with the emotional disorders, FSS are associated with a history of life adversity, with early life adversity and exposure to threat predicting functional somatic symptoms and disorders later in life (e.g., Craig, Boardman, Mills, Daly‐Jones, & Drake, 1993; Fearon & Hotopf, 2001; Heim et al., 2009; Lieb et al., 2002; Paras et al., 2009).…”

Section: Discussionmentioning

confidence: 99%

Annual Research Review: Functional somatic symptoms and associated anxiety and depression – developmental psychopathology in pediatric practice

Campo

2012

Child Psychology Psychiatry

181

158

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Annual Research Review: Functional somatic symptoms and associated anxiety and depression – developmental psychopathology in pediatric practice

Campo

2012

Child Psychology Psychiatry

181

158

View full text Add to dashboard Cite

show abstract

“…The treatment of common psychiatric presentations in primary care is essentially symptomatic with both non-specific and specific psychiatric interventions[140141]…”

Section: Diagnostic and Statistical Manual-5 And Primary Carementioning

confidence: 99%

“…The diagnostic categories recommended should complement existing physical symptoms cluster diagnosis (e.g., irritable bowel syndrome, non-cardiac chest pain, etc.,)[140]…”

Section: Diagnostic and Statistical Manual-5 And Primary Carementioning

confidence: 99%

See 1 more Smart Citation

Diagnostic and statistical manual‑5: Position paper of the Indian psychiatric society

Jacob

Kallivayalil

Mallik

et al. 2013

Indian J Psychiatry

View full text Add to dashboard Cite

The development of the Diagnostic and Statistical Manual-5 (DSM-5) has been an exhaustive and elaborate exercise involving the review of DSM-IV categories, identifying new evidence and ideas, field testing, and revising issues in order that it is based on the best available evidence. This report of the Task Force of the Indian Psychiatric Society examines the current draft of the DSM-5 and discusses the implications from an Indian perspective. It highlights the issues related to the use of universal categories applied across diverse cultures. It reiterates the evidence for mental disorders commonly seen in India. It emphasizes the need for caution when clinical categories useful to specialists are employed in the contexts of primary care and in community settings. While the DSM-5 is essentially for the membership of the American Psychiatric Association, its impact will be felt far beyond the boundaries of psychiatry and that of the United States of America. However, its atheoretical approach, despite its pretensions, pushes a purely biomedical agenda to the exclusion of other approaches to mental health and illness. Nevertheless, the DSM-5 should serve a gate-keeping function, which intends to set minimum standards. It is work in progress and will continue to evolve with the generation of new evidence. For the DSM-5 to be relevant and useful across the cultures and countries, it needs to be broad-based and consider social and cultural contexts, issues, and phenomena. The convergence and compatibility with International Classification of Diseases-11 is a worthy goal. While the phenomenal effort of the DSM-5 revision is commendable, psychiatry should continue to strive for a more holistic understanding of mental health, illness, and disease.

show abstract

“…Somatisierungssyndrome und affektive bzw. Angststörungen weisen vergleichbare Dysfunktionen in diversen Neurotransmittersystemen auf, die durch Psychopharmaka jeweils positiv beeinflusst werden können (Mayou 2007;Stahl 2003 (Rief et al 1995;Henningsen et al 2003). Komorbide psychische Störungen lassen sich konsequent psychopharmakologisch behandeln.…”

Section: Argumente Für Den Einsatz Von Psychopharmaka Bei Patienten Munclassified

Psychopharmakotherapie somatoformer Störungen und funktioneller somatischer Syndrome

Kapfhammer

2007

Psychiatrie

View full text Add to dashboard Cite

Patients presenting with bodily symptoms and complaints that are not explained by organic pathology or well known pathophysiological mechanisms form a major challenge to any health delivery system. From a perspective of psychiatric classification these medically unexplained somatic symptoms may be diagnosed as depressive and anxiety disorders on the one hand, as somatoform disorders on the other. Among medical specialties a separate diagnostic approach is taken to conceptualize functional somatic syndromes. From a therapeutic perspective psychotherapeutic strategies play a decisive role. There are also important issues that form a rationale for psychopharmacological interventions. The empirically significant overlap of somatoform syndromes and anxiety and depressive disorders, the conceptualization as affective spectrum disorders, the prominent role of pain symptoms, major neurobiological factors of underlying stress mechanisms, and high rates of psychiatric comorbidity in the often chronic courses of illness also stress the importance of psychopharmacotherapy. A survey will be presented on empirical studies of psychopharmacotherapy in somatoform disorders and some specific somatisation syndromes as fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and premenstrual syndrome. Findings of the antidepressant treatment of somatic symptoms in major depression will be summarised.

show abstract

Are Treatments for Common Mental Disorders Also Effective for Functional Symptoms and Disorder?

Cited by 25 publications

References 21 publications

Annual Research Review: Functional somatic symptoms and associated anxiety and depression – developmental psychopathology in pediatric practice

Annual Research Review: Functional somatic symptoms and associated anxiety and depression – developmental psychopathology in pediatric practice

Diagnostic and statistical manual‑5: Position paper of the Indian psychiatric society

Psychopharmakotherapie somatoformer Störungen und funktioneller somatischer Syndrome

Contact Info

Product

Resources

About